Targeting Ferroptosis: Small-molecule Inducers as Novel Anticancer Agents

Area of Science:

• Oncology
• Cell Death Research
• Biochemistry

Background:

• Ferroptosis is a regulated cell death pathway driven by iron-dependent lipid peroxidation and reactive oxygen species (ROS).
• Its role in cancer development and as a therapeutic target is gaining significant attention.
• Understanding ferroptosis mechanisms is crucial for developing new cancer treatments.

Purpose of the Study:

• To review the molecular mechanisms of ferroptosis.
• To evaluate the therapeutic potential of small-molecule ferroptosis inducers in cancer.
• To discuss the implications for cancer treatment strategies.

Main Methods:

• Consolidation of current research on ferroptosis.
• Analysis of small-molecule inducers (erastin, RSL3, sulfasalazine, sorafenib).
• Evaluation of ferroptosis's interplay with metabolic pathways and cell death modalities.

Main Results:

• Ferroptosis has distinct morphological and molecular signatures.
• It involves complex interactions with iron, lipid, and amino acid metabolism.
• Small molecules can selectively induce ferroptosis in cancer cells.

Conclusions:

• Targeting ferroptosis is a promising strategy to overcome resistance to conventional therapies.
• Further refinement of small molecules and investigation of synergistic effects are needed for clinical application.
• Future research should focus on safety, efficacy, and interactions with other cell death pathways.